Sg Americas Securities, LLC Protalix Bio Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024
SELL
$1.22 - $1.82 $16,029 - $23,912
-13,139 Reduced 37.97%
21,467 $27,000
Q4 2023

Jan 12, 2024
BUY
$1.34 - $1.85 $6,161 - $8,506
4,598 Added 15.32%
34,606 $62,000
Q3 2023

Oct 13, 2023
BUY
$1.49 - $2.02 $44,711 - $60,616
30,008 New
30,008 $50,000
Q2 2020

Jul 20, 2020
SELL
$2.19 - $4.5 $49,275 - $101,250
-22,500 Closed
0 $0
Q4 2019

Jan 28, 2020
BUY
$1.8 - $3.28 $40,500 - $73,800
22,500 New
22,500 $74,000

Others Institutions Holding PLX

# of Institutions
50
Shares Held
3.58M
Call Options Held
61.1K
Put Options Held
36.2K
View Full List

About Protalix BioTherapeutics, Inc.

PLX Quotes by TradingView
  • Ticker PLX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,753,400
  • Market Cap $87.1M
  • Description
  • Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...
More about PLX
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email